INKT
MiNK Therapeutics, Inc. · Healthcare · Market cap $61.2M
Insiders sold $19K net in the last 90 days ·1 seller, 0 buyers· latest Form 4 filed Jun 5, 2026
Insider Buying
$0
reported purchases (SEC code P)
Insider Selling
$47K
reported sales (SEC code S)
Unique Insiders
1
in the rolling window
Latest filing
Sep 2, 2026
Ryan Barbara
MiNK Therapeutics, Inc. (INKT) has 22 SEC Form 4 filings (32 transaction rows) in the rolling window, disclosed by 1 distinct insider. Most recent filing: Sep 2, 2026.
Inside the rolling window, 1 insider at MiNK Therapeutics, Inc. reported no open-market purchases and 5 open-market sales totaling $47K. The most active filer is Director Ryan Barbara with 5 filings. The most recent open-market filing is a sale of 1,500 shares by Director Ryan Barbara, dated Jun 4, 2026, worth $19K.
- Industry:Biotechnology
- CEO:Jennifer S. Buell
- Employees:15
- HQ:New York City, NY, US
- IPO:2021-10-15
Frequently asked questions
How many SEC Form 4 insider filings does INKT have?
MiNK Therapeutics, Inc. (INKT) has 22 SEC Form 4 filings (32 transaction rows) in the rolling 365-day window, disclosed by 1 distinct insider. Most recent filing: Sep 2, 2026.
When was the most recent SEC Form 4 filing for INKT?
The most recent Form 4 filing for INKT on Tracefour is dated Sep 2, 2026.
Who is the most active insider at INKT?
The most active SEC Form 4 filer at INKT in the rolling window is Director Ryan Barbara, with 5 filings.
What is the net insider flow at INKT over the last 6 months?
Over the trailing 180 days, insiders at INKT have net sold $41K based on SEC Form 4 disclosures.
What is the total insider buy and sell value at INKT in the current window?
Inside the rolling window, insiders at INKT bought $0 and sold $47K based on SEC Form 4 filings.
Can I get alerts for INKT insider trading?
Yes. Tracefour sends a free email when a new SEC Form 4 purchase or sale is filed at MiNK Therapeutics, Inc. (INKT). Alerts are set per company from the page itself, there is no paid tier, and each email links to the original filing on SEC EDGAR.
Related companies
MiNK Therapeutics, Inc. is in the Healthcare sector.